证券代码：605088 证券简称：冠盛股份 公告编号：2026-007 温州市冠盛汽车零部件集团股份有限公司 关于上证 E 互动有关问题回复的说明公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 温州市冠盛汽车零部件集团股份有限公司（以下简称"公司"）于近日在上 证 E 互动平台就投资者关于固液混合电池产线订单和机器人业务订单的问题做 出回复，为保障广大投资者的合法权益，公司就相关业务情况补充说明，并进行 进一步风险提示： 一、E 互动回复相关情况的说明 针对以上回复做进一步说明如下：子公司浙江冠盛东驰能源科技有限公司 （以下简称"冠盛东驰"）投资建设的固液混合电池项目产品并非固态电池，不 适于新能源汽车领域。目前固液电池量产线还未下线，冠盛东驰 2025 年度实现 营业收入 403.30 万元，占 2025 年度公司营业收入的 0.09%，实现净利润 -2,347.69 万元，以上数据未经审计，对公司的影响极小。公司将根据具体合作 业务的开展情况，及时履行信息披露义务，敬请投资者留意投资风险。 2、机器人业务相关回 ...

Group 1 - Fangda Carbon plans to acquire 100% equity of Tianjin Tongda Huanyu Logistics Co., Ltd. for 319 million yuan [1] - Xiamen Tungsten intends to acquire 39% equity of Jiujiang Dadi Mining Development Co., Ltd. and has signed an intention agreement with a transferor [6] - Wenkai Co. has won a bid for a landscape project worth 50.8162 million yuan [7] Group 2 - Changchun High-tech's subsidiary Jin Sai Pharmaceutical received approval for a clinical trial application for GenSci136, a treatment for IgA nephropathy [3] - China National Pharmaceutical has received drug registration certificates for fumaric acid volnoral tablets, used for treating reflux esophagitis [12] - Zhenhua Group plans to issue convertible bonds not exceeding 1.2 billion yuan [26] Group 3 - CSG Holding's stock may undergo a control change due to share pledge judicial transfer [30] - Ningbo Yunsheng plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [19] - Keda Guochuang's controlling shareholder intends to transfer 5% of the company's shares through an agreement [28] Group 4 - A number of companies, including Finer Pharma, Yixing Guoyuan Investment, and others, have announced plans to reduce their shareholdings by various percentages [2][4][9][11][15][16][20][21][22][23][25][29] - Highweida plans to repurchase shares worth 30 to 35 million yuan [17] - ST Zhongzhu is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [24] Group 5 - A number of companies, including Jiekang Equipment and others, have faced legal issues or penalties [27][40] - Aclaris Therapeutics has clarified that reports regarding its robotic products entering mass production were misinterpreted [41]

Clarifications - Guansheng Co. clarified that its core product, the intelligent bionic joint arm, currently has no orders and has not generated operating income, stating that media reports were misinterpretations [1] - Haiguang Information indicated that its business layout does not currently involve TPU chips and remains focused on core strategic products [1] Shareholding Reductions - Shareholders of Congsheng Co. plan to collectively reduce no more than 5% of the company's shares, with the controlling shareholder and actual controller Wang Zongyou and Tian Niabin planning to reduce a combined total of no more than 3.00%, and other specific shareholders planning to reduce 1.63% and 0.37% respectively [2] - Xinling Electric's director and general manager Zhang Pengchun plans to reduce no more than 1.28% of the company's total shares within three months after the announcement [2] - Senba Sensor's shareholder Ganzhou Yingbei Investment Development Co., Ltd. plans to reduce no more than 3% of the company's total shares [3] - Changchuan Technology's actual controller's concerted action partner plans to reduce no more than 1.1128% of the company's total shares through block trading [2] - GCL-Poly Energy's shareholder Shenzhen Qianhai Oriental Entrepreneurship Financial Holdings Co., Ltd. plans to reduce no more than 1.01% of the company's total shares within three months after the announcement [2] Performance Reports - AVIC Optoelectronics released a preliminary report for 2025, indicating a net profit attributable to shareholders of 2.124 billion yuan, a year-on-year decrease of 36.69% [4] - ST Jinglan announced an expected significant decline in operating performance for 2025, with its stock trading experiencing severe abnormal fluctuations [4] Other News - Jieqiang Equipment and its actual controller Pan Feng were convicted of unit bribery, with the company fined 1.5 million yuan and Pan Feng sentenced to one year and nine months in prison, along with a fine of 1.5 million yuan [5] - ST Cuihua is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Wentai Technology and Luxshare ICT are in dispute over the performance of an agreement regarding an asset package in India, with the matter submitted to the Singapore International Arbitration Centre [5] - Sunrock Electronics filed a lawsuit against Murata Manufacturing Co., Ltd. for malicious intellectual property litigation, seeking compensation of 1.5 million yuan for economic losses incurred [5] - ST Jieneng is undergoing judicial transfer procedures for pledged shares, which may lead to a change in company control, with stock suspension starting from February 10, 2026 [5] - Yutai Micro's shareholder agreement has expired, resulting in a change in actual control from Shi Qing and Ouyang Yufei to no actual controller [5]

Group 1 - Xi Jinping emphasized the importance of technological self-reliance for building a modern socialist country during his visit to the National Innovation Park in Beijing, where he observed advancements in AI and robotics [1] - The Shanghai, Shenzhen, and Beijing stock exchanges announced a package of measures to optimize refinancing processes for high-quality listed companies, aiming to enhance refinancing efficiency [2] - The Ministry of Commerce plans to implement a vehicle trade-in program by 2026 to boost automotive consumption, alongside other reforms in the automotive circulation sector [3] Group 2 - Zhongke Shuguang announced plans to issue convertible bonds to raise up to 8 billion yuan for advanced computing cluster projects focused on AI [5] - Efort plans to acquire 100% of Shengpu shares, with stock resuming trading on February 10; Hainan Mining intends to acquire 69.9% of Fengrui Fluorine Industry shares, also resuming trading [6] - Jinhui shares announced a 210 million yuan acquisition of 100% of Fusheng Mining, which holds a gold mining license with an annual production capacity of 50,000 tons [6] Group 3 - Mengguli announced an investment of 929 million yuan to build a project for producing 30,000 tons of lithium-ion battery cathode materials annually [7] - Yuanjie Technology plans to invest 1.251 billion yuan in the second phase of a semiconductor chip and device R&D production base, focusing on high-speed optical chips [7] - Cuihua Jewelry is under investigation by the CSRC for suspected violations of information disclosure regulations [8] Group 4 - The transportation regulatory office conducted a meeting with Gaode Dache, highlighting issues such as inadequate management of partner ride-hailing platforms and improper emergency responses [13] - The U.S. stock market saw gains, with major indices rising, particularly Oracle, which increased by over 9% [14] - COMEX gold futures rose by 2.1% to $5084.2 per ounce, while silver futures increased by 8% to $83.05 per ounce [15]

冠盛股份（605088）(605088.SH)公告，公司关注到网上有个别媒体发布了关于"冠盛股份在沪发布智能 仿生关节臂"的相关报道。报道中提到公司人形机器人核心部件业务迈入商业量产阶段，公司智能仿生 关节臂产品在生物医药实验装备领域，有过千套配套订单意向。上述报道内容系媒体误读，并非公司表 述。公司主营业务未发生变更，仍以汽车底盘系统零部件的研发、生产和销售为主要业务，当前机器人 智能仿生关节臂产品无订单且未产生营业收入。相关媒体报道措辞不准确，产品未进入量产阶段且距离 量产还存在很长的一段距离。 ...

智通财经APP讯，冠盛股份(605088.SH)公告，公司关注到网上有个别媒体发布了关于"冠盛股份在沪发 布智能仿生关节臂"的相关报道。报道中提到公司人形机器人核心部件业务迈入商业量产阶段，公司智 能仿生关节臂产品在生物医药实验装备领域，有过千套配套订单意向。上述报道内容系媒体误读，并非 公司表述。公司主营业务未发生变更，仍以汽车底盘系统零部件的研发、生产和销售为主要业务，当前 机器人智能仿生关节臂产品无订单且未产生营业收入。相关媒体报道措辞不准确，产品未进入量产阶段 且距离量产还存在很长的一段距离。 ...

公司主营业务未发生变更，仍以汽车底盘系统零部件的研发、生产和 销售为主要业务，当前机器人智能仿生关节臂产品无订单且未产生营业收 入。相关媒体报道措辞不准确，产品未进入量产阶段且距离量产还存在很 长的一段距离。后续若触及信息披露标准，将严格按照相关法律法规的规 定履行信息披露义务。 二、相关风险提示 证券代码：605088 证券简称：冠盛股份 公告编号：2026-006 温州市冠盛汽车零部件集团股份有限公司 关于媒体报道的澄清公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 近日，温州市冠盛汽车零部件集团股份有限公司关注到网上有个别媒 体发布了关于"冠盛股份在沪发布智能仿生关节臂"的相关报道。公司知 悉后高度重视，为避免相关信息对广大投资者造成误导，对有关情况进行 了核实，现予以澄清说明。 一、澄清声明 近日，温州市冠盛汽车零部件集团股份有限公司（以下简称"公司"） 关注到网上有个别媒体发布了关于"冠盛股份在沪发布智能仿生关节臂" 的相关报道，报道中提到公司人形机器人核心部件业务迈入商业量产阶段， 公司 ...

格隆汇2月9日｜冠盛股份公告称，近日，网上个别媒体发布"冠盛股份在沪发布智能仿生关节臂"相关报 道，提及公司人形机器人核心部件业务迈入商业量产阶段等内容，系媒体误读。公司主营业务仍为汽车 底盘系统零部件，当前机器人智能仿生关节臂产品无订单、未产生营收，未进入量产阶段。公司将联系 媒体删除不实表述并追责。此外，公司股票自2026年1月1日以来累计涨幅达16.07%，高于同期行业及 沪指涨幅，提醒投资者注意风险。 ...

冠盛股份发布澄清公告，针对媒体报道的"冠盛股份在沪发布智能仿生关节臂"进行辟谣。公司主营业务 未发生变更，仍以汽车底盘系统零部件的研发、生产和销售为主要业务，当前机器人智能仿生关节臂产 品无订单且未产生营业收入。相关媒体报道措辞不准确，产品未进入量产阶段且距离量产还存在很长的 一段距离。 ...

证券日报网讯2月9日，冠盛股份（605088）在互动平台回答投资者提问时表示，聚合物路线相比其他技 术路线具有成本低，工艺兼容性高、供应链成熟度更高等优势。 ...